LEO Pharma A/S is an independent, research-based pharmaceutical company founded in 1908. LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. To realize our vision of becoming the preferred dermatology care partner improving people’s lives around the world, we are expanding into new regions and markets, reaching more patients and societies with drugs and therapies that address unmet medical needs. The company is headquartered in Ballerup, Denmark and is wholly owned by the LEO Foundation.
LEO Pharma K.K. was established in June 2010 as the wholly-owned Japanese subsidiary of LEO Pharma A/S. The company aims to establish a solid position as a specialty pharmaceutical company in Japan with expertise in the field of dermatology. LEO Pharma’s mission is “we help people achieve healthy skin.” By listening to people with skin conditions, LEO Pharma develops complete care solutions that meet patient needs. For more information, please visit our website.